Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease

Uzma Rani; Ajay Rana

doi:10.14309/crj.0000000000000624

Back

Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease

Journal article

Open access

Peer reviewed

Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease

Uzma Rani and Ajay Rana

ACG case reports journal, Vol.8(7), 00624

07/01/2021

DOI: 10.14309/crj.0000000000000624

PMCID: PMC8270588

PMID: 34258304

Files and links (1)

url

https://doi.org/10.14309/crj.0000000000000624View

Published (Version of record) Open Access

Abstract

Anti-tumor necrosis factor-alpha agents are used for the treatment of inflammatory bowel disease. Central nervous system infections are rare adverse effects of these medications, and to the best of our knowledge, there are only 2 case reports from the pediatric patient population. We report a case of an 8-year-old patient with Crohn's disease who developed Listeria meningitis while on infliximab.

Gastroenterology & Hepatology

Life Sciences & Biomedicine

Science & Technology

Details

Title: Subtitle: Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease
Creators: Uzma Rani - SUNY Upstate Medical University
Ajay Rana - SUNY Upstate Medical University
Resource Type: Journal article
Publication Details: ACG case reports journal, Vol.8(7), 00624
Publisher: Lippincott Williams & Wilkins
DOI: 10.14309/crj.0000000000000624
PMID: 34258304
PMCID: PMC8270588
eISSN: 2326-3253
Number of pages: 3
Language: English
Date published: 07/01/2021
Academic Unit: Stead Family Department of Pediatrics; General Pediatrics and Adolescent Medicine
Record Identifier: 9984701837102771

Metrics

4 Record Views

See more details